ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Hot Features

Registration Strip Icon for alerts Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.

PRPO Precipio Inc

5,7499
-0,1501 (-2,54%)
01 Mai 2024 - Geschlossen
Verzögert um 15 Minuten
Name Symbol Markt Aktientyp
Precipio Inc PRPO NASDAQ Common Stock
  Änderung Änderung % Aktuell Zeit
-0,1501 -2,54% 5,7499 02:00:00
Handelsbeginn Niedrig Hoch Schlusskurs Handelsende
5,91 5,61 6,079 5,7499 5,90
more quote information »

Aktuelle News

Datum Zeit Quelle Überschrift
25.3.202422:00GLOBEPrecipio Announces Year end 2023 Shareholder Update Call
13.2.202416:00GLOBEPrecipio to Report $15.2M for FY-2023 (unaudited) Revenues,..
06.2.202416:00GLOBEPrecipio and Cardinal Health Sign Distribution Agreement for..
23.1.202416:00GLOBEPrecipio’s Q4-2023 Cash Burn From Operations (unaudited)..
19.1.202422:05EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
17.1.202416:30GLOBEPrecipio Signs Distribution Agreement For IV-Cell® and..
04.1.202422:33EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04.1.202422:30EDGAR2Form 3 - Initial statement of beneficial ownership of..
02.1.202423:01EDGAR2Form 8-K - Current report
02.1.202415:00GLOBEPrecipio Announces Christina Valauri joins the Board of..
14.12.202323:00EDGAR2Form 8-K - Current report
14.12.202322:30GLOBEPrecipio Management Shares Thoughts on 2023, and Looks Ahead..
16.11.202323:15EDGAR2Form 8-K - Current report
16.11.202323:00GLOBEPrecipio Announces Q3-2023 Shareholder Update Call
13.11.202322:03EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
31.10.202321:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26.10.202322:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26.10.202322:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26.10.202322:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18.10.202315:00GLOBEPrecipio to Report $4.5M Q3-2023 Revenues, Double From..
06.10.202322:34EDGAR2Form 8-K - Current report
03.10.202316:00GLOBEPrecipio’s Q3 Cash Burn From Operations (unaudited) Declines..
28.9.202315:00GLOBEPrecipio Continues to Sign New HemeScreen™ Customers
25.9.202317:00GLOBEPrecipio Reduces Product Revenue Result Needed for Cash Flow..
21.9.202323:10EDGAR2Form 8-K - Current report
14.9.202322:41EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14.9.202322:41EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14.9.202322:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14.9.202322:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14.9.202322:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14.9.202322:39EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13.9.202315:30GLOBEPrecipio’s Pathology Division Exceeds Breakeven Revenues in..
14.8.202322:00EDGAR2Form 8-K - Current report
11.8.202322:31EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
10.8.202323:00GLOBEPrecipio Announces Q2-2023 Shareholder Update Call
08.8.202315:00GLOBEPrecipio Launches Its Much-Anticipated Quantitative BCR-ABL..
03.8.202315:00GLOBEPrecipio’s Operational Efficiency Measures Continue To..
01.8.202315:00GLOBEPrecipio Unaudited Q2-2023 Revenues Show combined increase..
07.7.202322:30EDGAR2Form S-1 - General form for registration of securities under..
14.6.202315:49GLOBEPrecipio’s Omnia™ Methodology Enables Diagnosis of MDS With..
13.6.202315:00GLOBEPrecipio Enters into Collaboration with Prestigious New..
08.6.202314:30GLOBEPrecipio, Inc. Announces Pricing of $2 Million Registered..
07.6.202315:30GLOBEProjected cash burn reduced by $1.5 million annually from..
22.5.202317:00GLOBEPrecipio’s Lab Detects BCR-ABL1 Oncogene Co-Expression of..
17.5.202322:00GLOBEPrecipio Shares Growth Catalysts For HemeScreen
15.5.202322:00GLOBEPrecipio Announces Q1-2023 Shareholder Update Call
04.5.202319:00GLOBEPrecipio Adds Substantial Pathology Customer to its..
04.5.202316:00GLOBEPrecipio Signs Another HemeScreen™ Customer

Kürzlich von Ihnen besucht

Delayed Upgrade Clock